Report on the XXXVIII Congress of ERA-EDTA, Vienna, June, 2001;Sprawozdanie z XXXVIII Kongresu ERA-EDTA, Wiedeń, czerwiec 2001 r

Polski Merkuriusz Lekarski

Volumn 13, Issue 77, 2002, Pages 443-445

  Zelichowski, Grzegorz ^a   Wierzbicki, Przemysław ^a  

^a Klinika Nefrologii ze Stacja Dializ   (Poland)

Author keywords

Calcium phosphorus metabolism; Fabry disease; Renal anaemia; Vascular access to hemodialysis

Indexed keywords

EDETIC ACID;

CALCIUM METABOLISM; CONFERENCE PAPER; DIALYSIS; FABRY DISEASE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; NEPHROLOGY; ORGANIZATION; PHOSPHATE METABOLISM; RENAL ANEMIA; SYMPOSIUM; VASCULAR ACCESS;

ANEMIA; CALCIUM PHOSPHATES; CATHETERS, INDWELLING; EUROPE; FABRY DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; SOCIETIES, MEDICAL;

EID: 0036445662     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Bleyer A.J. i wsp.: A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am. J. Kidney Dis., 1999, 33, 694-701.
2. Block G.A., Port F.K.: Reevaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am. J. Kidney Dis., 2000, 35, 1226-1237.
3. Foley R.N., Parfrey P., Morgan J.: Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomiopathy. Kidney Int. 2000, 58, 1325-1335.
4. Inoue S. i wsp.: PTA revises fully failed arteriovenous fistulae. Nephrol. Dial, Transplant., 2001, 16, A151 (abstr).
5. Pietura R. i wsp.: Stenosis in well-functioning vascular access for hemodialysis - Doppler ultrasound evaluation. NDT, 2001, 16, A155 (abstr).
6. Rumberger J.A. i wsp.: Electron beam computed tomographic coronary calcium scaning: A review and guidelines for use in asymptomatic persons. Mayo Clinic Proc., 1999, 74, 243-252.
7. Sandinavian Simvastatin Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 1994, 344, 1383-1389.
8. The Lovastatin Study Group III: A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. JAMA, 1988, 260. 359-366.